Evidence map›Paper›PMID 30779763›Full record

ArticlePloS one2019

Immune-enhancing effects of anionic macromolecules extracted from Codium fragile on cyclophosphamide-treated mice.

Chaiwat Monmai, SangGuan You, Woo Jung Park

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Foods (Basel, Switzerland) · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Immunoenhancing Effects ofJournal of microbiology and biotechnology · 2022
    Article
  8. SBT (Composed ofAntioxidants (Basel, Switzerland) · 2022
    Article
  9. Review
  10. Enhancement of Immune Activities of Mixtures withFoods (Basel, Switzerland) · 2020
    Article
  11. Co-immunomodulatory Activities of Anionic Macromolecules Extracted fromJournal of microbiology and biotechnology · 2020
    Article
  12. The complete plastid genome and phylogenetic analysis ofMitochondrial DNA. Part B, Resources · 2020
    Article
  13. Effects of Polysaccharide fromOxidative medicine and cellular longevity · 2020
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chaiwat MonmaiDepartment of Marine Food Science and Technology, Gangneung-Wonju National University, Gangneung, Gangwon, Korea.
SangGuan YouDepartment of Marine Food Science and Technology, Gangneung-Wonju National University, Gangneung, Gangwon, Korea.
Woo Jung ParkDepartment of Marine Food Science and Technology, Gangneung-Wonju National University, Gangneung, Gangwon, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immune-regulation and homeostasis are critical in cancer therapy and immunomodulatory biomaterials have been used to decrease side effects of immunosuppressant drugs. Anionic macromolecules (CFAMs) were isolated from the seaweed Codium fragile, and its immune-enhancing biological activities were examined in CY-induced immunosuppressed mice. CFAMs improved the splenic lymphocyte proliferation, NK cell activity, and spleen index. The expression of immune-associated genes was highly upregulated in splenic lymphocytes, and gene expression was differently regulated according to mitogens such as T-cell (Con A) and B-cell (LPS) mitogens. Additionally, CFAMs boosted the proliferation, NO production, and phagocytosis of peritoneal macrophages. CFAMs also considerably stimulated immune-associated gene expression in peritoneal macrophages. Moreover, our results showed CFAMs mediated its immune-enhancing effects via the MAPK pathway. These suggested CFAMs can be used as a potent immunomodulatory material under immune-suppressive condition. Furthermore, CFAMs may also be used as a bio-functional and pharmaceutical material for improving human health and immunity.

Indexed as

Adjuvants, ImmunologicAnimalsAnionsAntineoplastic Agents, AlkylatingChlorophytaCyclophosphamideKiller Cells, NaturalLymphocyte ActivationMacromolecular SubstancesMacrophages, PeritonealMaleMAP Kinase Signaling SystemMiceMice, Inbred BALB CNF-kappa BPhagocytosisAdjuvants, ImmunologicAnionsAntineoplastic Agents, AlkylatingCyclophosphamideMacromolecular SubstancesNF-kappa B

Identifiers

PMID30779763
PMCPMC6380620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.